Literature DB >> 23318991

Preconditioning by isoflurane elicits mitochondrial protective mechanisms independent of sarcolemmal KATP channel in mouse cardiomyocytes.

Maria Muravyeva1, Filip Sedlic, Nicholas Dolan, Zeljko J Bosnjak, Anna Stadnicka.   

Abstract

Cardiac mitochondria and the sarcolemmal (sarc)KATP channels contribute to cardioprotective signaling of anesthetic-induced preconditioning. Changes in mitochondrial bioenergetics influence the sarcolemmal ATP-sensitive K (sarcKATP) channel function, but whether this channel has impacts on mitochondria is uncertain. We used the mouse model with deleted pore-forming Kir6.2 subunit of sarcKATP channel (Kir6.2 KO) to investigate whether the functional sarcKATP channels are necessary for isoflurane activation of mitochondrial protective mechanisms. Ventricular cardiomyocytes were isolated from C57Bl6 wild-type (WT) and Kir6.2 KO mouse hearts. Flavoprotein autofluorescence, mitochondrial reactive oxygen species production, and mitochondrial membrane potential were monitored by laser-scanning confocal microscopy in intact cardiomyocytes. Cell survival was assessed using H2O2-induced stress. Isoflurane (0.5 mM) increased flavoprotein fluorescence to 180% ± 14% and 190% ± 15% and reactive oxygen species production to 118% ± 2% and 124% ± 6% of baseline in WT and Kir6.2 KO myocytes, respectively. Tetramethylrhodamine ethyl ester fluorescence decreased to 84% ± 6% in WT and to 86% ± 4% in Kir6.2 KO myocytes. This effect was abolished by 5HD. Pretreatment with isoflurane decreased the stress-induced cell death from 31% ± 1% to 21% ± 1% in WT and from 44% ± 2% to 35% ± 2% in Kir6.2 KO myocytes. In conclusion, Kir6.2 deletion increases the sensitivity of intact cardiomyocytes to oxidative stress, but does not alter the isoflurane-elicited protective mitochondrial mechanisms, suggesting independent roles for cardiac mitochondria and sarcKATP channels in anesthetic-induced preconditioning by isoflurane.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23318991      PMCID: PMC3648596          DOI: 10.1097/FJC.0b013e318285f55b

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  46 in total

1.  HMR 1098 is not an SUR isotype specific inhibitor of heterologous or sarcolemmal K ATP channels.

Authors:  Hai Xia Zhang; Alejandro Akrouh; Harley T Kurata; Maria Sara Remedi; Jennifer S Lawton; Colin G Nichols
Journal:  J Mol Cell Cardiol       Date:  2010-12-23       Impact factor: 5.000

2.  A family of sulfonylurea receptors determines the pharmacological properties of ATP-sensitive K+ channels.

Authors:  N Inagaki; T Gonoi; J P Clement; C Z Wang; L Aguilar-Bryan; J Bryan; S Seino
Journal:  Neuron       Date:  1996-05       Impact factor: 17.173

3.  Openings of cardiac KATP channel by oxygen free radicals produced by xanthine oxidase reaction.

Authors:  K Tokube; T Kiyosue; M Arita
Journal:  Am J Physiol       Date:  1996-08

4.  Molecular basis of protein kinase C-induced activation of ATP-sensitive potassium channels.

Authors:  P E Light; C Bladen; R J Winkfein; M P Walsh; R J French
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

5.  Direct activation of the ATP-sensitive potassium channel by oxygen free radicals in guinea-pig ventricular cells: its potentiation by MgADP.

Authors:  K Ichinari; M Kakei; T Matsuoka; H Nakashima; H Tanaka
Journal:  J Mol Cell Cardiol       Date:  1996-09       Impact factor: 5.000

Review 6.  K(ATP) channels and preconditioning: a re-examination of the role of mitochondrial K(ATP) channels and an overview of alternative mechanisms.

Authors:  Peter J Hanley; Jürgen Daut
Journal:  J Mol Cell Cardiol       Date:  2005-07       Impact factor: 5.000

Review 7.  Sarcolemmal versus mitochondrial ATP-sensitive K+ channels and myocardial preconditioning.

Authors:  G J Gross; R M Fryer
Journal:  Circ Res       Date:  1999-05-14       Impact factor: 17.367

8.  Defective insulin secretion and enhanced insulin action in KATP channel-deficient mice.

Authors:  T Miki; K Nagashima; F Tashiro; K Kotake; H Yoshitomi; A Tamamoto; T Gonoi; T Iwanaga; J Miyazaki; S Seino
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

9.  Method for isolation of adult mouse cardiac myocytes for studies of contraction and microfluorimetry.

Authors:  B M Wolska; R J Solaro
Journal:  Am J Physiol       Date:  1996-09

10.  Blockade of ischaemic preconditioning in dogs by the novel ATP dependent potassium channel antagonist sodium 5-hydroxydecanoate.

Authors:  J A Auchampach; G J Grover; G J Gross
Journal:  Cardiovasc Res       Date:  1992-11       Impact factor: 10.787

View more
  2 in total

Review 1.  Differential expression of microRNAs in ischemic heart disease.

Authors:  Minwoo A Song; Alexandra N Paradis; Maresha S Gay; John Shin; Lubo Zhang
Journal:  Drug Discov Today       Date:  2014-10-23       Impact factor: 7.851

2.  The Role of SUMO-Conjugating Enzyme Ubc9 in the Neuroprotection of Isoflurane Preconditioning Against Ischemic Neuronal Injury.

Authors:  Li Tong; Zhixin Wu; Mingzi Ran; Yu Chen; Lujia Yang; Haopeng Zhang; Lina Zhang; Hailong Dong; Lize Xiong
Journal:  Mol Neurobiol       Date:  2014-06-25       Impact factor: 5.590

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.